Arca
Skip to content
Tools
Tools

-ermin

Versions of the body's growth factor proteins.

  • Drugs ending in -ermin: 29
  • Approved somewhere: 7
  • With a US drug page: 5

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-ermin
Class
Versions of the body's growth factor proteins
Most common targets
FGFR2 (2), FGF1, KLB (2), BMPR1A (2), BMPR2 (2), BMPR1B (2), ACVR1 (2), IGF1R (2), Neurotrophic tyrosine kinase receptor (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -ermin or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
CenegerminApprovedNeurotrophic tyrosine kinase receptorNeurotrophic tyrosine kinase receptor agonist
Cimaglermin alfaPhase 1——
Oremepermin alfaPhase 1——
TelberminPhase 2FLT1, KDRVascular endothelial growth factor receptor 1 and 2 (Flt-1 and KDR) agonist
NepiderminPhase 3——
PaliferminApprovedFGFR2Fibroblast growth factor receptor 2 agonist
PegozaferminPhase 3——
TraferminPhase 3FGFR2Fibroblast growth factor receptor 2 agonist
AldaferminPhase 2FGF1, KLB, FGFR4, KLBFGF1/KLB activator
PegbelferminPhase 2FGF1, KLBFGF1/KLB agonist
SpriferminPhase 2——
VelaferminPhase 2——
Efimosfermin alfaPhase 1——
EfruxiferminPhase 1——
EmfilerminPhase 1——
TasonerminApproved—Unknown
DulanerminPhase 2TNFRSF10A, TNFRSF10BTRAIL receptor-1 agonist
PegipanerminPhase 2——
Rilunermin alfaPhase 2——
Efgivanermin alfaPhase 1——
Eftozanermin alfaPhase 1——
Dibotermin alfaApprovedBMPR1A, ACVR2B, BMPR2, BMPR1B and 2 moreBone morphogenetic protein receptor type-1A agonist
Eptotermin alfaApprovedBMPR1A, BMPR2, BMPR1B, ACVR1Bone morphogenetic protein receptor type-1A agonist
AvoterminPhase 3——
RadoterminPhase 2——
BecaplerminApprovedPDGFRA, PDGFRBPlatelet-derived growth factor receptor agonist
MecaserminApprovedIGF1RInsulin-like growth factor I receptor agonist
Mecasermin rinfabatePhase 2IGF1RInsulin-like growth factor I receptor agonist
LiaterminPhase 1GFRA1GDNF family receptor alpha-1 agonist

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.